CHINA PHARMA HOLDINGS, INC. Proceeds from Long-term Lines of Credit
CHINA PHARMA HOLDINGS, INC. (CPHI) had Proceeds from Long-term Lines of Credit of $1.40 million as of 2023-09-25, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2022-06-30 was -$862.76K.
- CHINA PHARMA HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2022-03-31 was -$47.24K.
- CHINA PHARMA HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2022 was -$2.14M.
- CHINA PHARMA HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2021 was -$2.53M.
USD
| Period end | Proceeds from Long-term Lines of Credit | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2023-09-25 | $1.40M 10-Q · filed 2026-08-14 | |||
| 2022-12-31 | -$2.14M 10-K · filed 2023-03-30 | |||
| 2022-06-30 | -$862.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$910.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$47.24K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | -$2.53M 10-K · filed 2023-03-30 |
CNY
| Period end | Proceeds from Long-term Lines of Credit |
|---|---|
| 2023-09-25 | 10.00M CNY 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |